Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 70

1.

Congenital Chagas Disease in the United States: Cost Savings through Maternal Screening.

Stillwaggon E, Perez-Zetune V, Bialek SR, Montgomery SP.

Am J Trop Med Hyg. 2018 Jun;98(6):1733-1742. doi: 10.4269/ajtmh.17-0818. Epub 2018 Apr 26.

2.

Hearing Trajectory in Children with Congenital Cytomegalovirus Infection.

Lanzieri TM, Chung W, Leung J, Caviness AC, Baumgardner JL, Blum P, Bialek SR, Demmler-Harrison G; Congenital Cytomegalovirus Longitudinal Study Group.

Otolaryngol Head Neck Surg. 2018 Apr;158(4):736-744. doi: 10.1177/0194599818758247. Epub 2018 Mar 20.

3.

Urinary Cytomegalovirus Shedding in the United States: The National Health and Nutrition Examination Surveys, 1999-2004.

Amin MM, Bialek SR, Dollard SC, Wang C.

Clin Infect Dis. 2018 Aug 1;67(4):587-592. doi: 10.1093/cid/ciy143.

4.

Intelligence and Academic Achievement With Asymptomatic Congenital Cytomegalovirus Infection.

Lopez AS, Lanzieri TM, Claussen AH, Vinson SS, Turcich MR, Iovino IR, Voigt RG, Caviness AC, Miller JA, Williamson WD, Hales CM, Bialek SR, Demmler-Harrison G; Congenital Cytomegalovirus Longitudinal Study Group.

Pediatrics. 2017 Nov;140(5). pii: e20171517. doi: 10.1542/peds.2017-1517.

5.

Long-term outcomes of children with symptomatic congenital cytomegalovirus disease.

Lanzieri TM, Leung J, Caviness AC, Chung W, Flores M, Blum P, Bialek SR, Miller JA, Vinson SS, Turcich MR, Voigt RG, Demmler-Harrison G.

J Perinatol. 2017 Jul;37(7):875-880. doi: 10.1038/jp.2017.41. Epub 2017 Apr 6.

6.

Hearing Loss in Children With Asymptomatic Congenital Cytomegalovirus Infection.

Lanzieri TM, Chung W, Flores M, Blum P, Caviness AC, Bialek SR, Grosse SD, Miller JA, Demmler-Harrison G; Congenital Cytomegalovirus Longitudinal Study Group.

Pediatrics. 2017 Mar;139(3). pii: e20162610. doi: 10.1542/peds.2016-2610. Epub 2017 Feb 16.

7.

Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China.

Wang S, Wang T, Zhang W, Liu X, Wang X, Wang H, He X, Zhang S, Xu S, Yu Y, Jia X, Wang M, Xu A, Ma W, Amin MM, Bialek SR, Dollard SC, Wang C.

Medicine (Baltimore). 2017 Feb;96(5):e6007. doi: 10.1097/MD.0000000000006007.

8.

Update on Incidence of Herpes Zoster Among Children and Adolescents After Implementation of Varicella Vaccination, Antelope Valley, CA, 2000 to 2010.

Civen R, Marin M, Zhang J, Abraham A, Harpaz R, Mascola L, Bialek SR.

Pediatr Infect Dis J. 2016 Oct;35(10):1132-6. doi: 10.1097/INF.0000000000001249.

PMID:
27622686
9.

What Do We Know About Chagas Disease in the United States?

Montgomery SP, Parise ME, Dotson EM, Bialek SR.

Am J Trop Med Hyg. 2016 Dec 7;95(6):1225-1227. doi: 10.4269/ajtmh.16-0213. Epub 2016 Jul 11.

10.

Influence of parity and sexual history on cytomegalovirus seroprevalence among women aged 20-49 years in the USA.

Lanzieri TM, Kruszon-Moran D, Gambhir M, Bialek SR.

Int J Gynaecol Obstet. 2016 Oct;135(1):82-5. doi: 10.1016/j.ijgo.2016.03.032. Epub 2016 Jun 29.

11.

Risk Factors for Herpes Zoster Among Adults.

Marin M, Harpaz R, Zhang J, Wollan PC, Bialek SR, Yawn BP.

Open Forum Infect Dis. 2016 Jun 11;3(3):ofw119. doi: 10.1093/ofid/ofw119. eCollection 2016 Sep.

12.

Self-reported herpes zoster, pain, and health care seeking in the Health and Retirement Study: implications for interpretation of health care-based studies.

Hales CM, Harpaz R, Bialek SR.

Ann Epidemiol. 2016 Jun;26(6):441-446.e3. doi: 10.1016/j.annepidem.2016.04.006. Epub 2016 Apr 13.

13.

Cytomegalovirus IgM Seroprevalence among Women of Reproductive Age in the United States.

Wang C, Dollard SC, Amin MM, Bialek SR.

PLoS One. 2016 Mar 18;11(3):e0151996. doi: 10.1371/journal.pone.0151996. eCollection 2016.

14.

Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.

Perella D, Wang C, Civen R, Viner K, Kuguru K, Daskalaki I, Schmid DS, Lopez AS, Tseng HF, Newbern EC, Mascola L, Bialek SR.

Pediatrics. 2016 Apr;137(4). pii: e20152802. doi: 10.1542/peds.2015-2802. Epub 2016 Mar 14.

15.

Varicella immunization requirements for US colleges: 2014-2015 academic year.

Leung J, Marin M, Leino V, Even S, Bialek SR.

J Am Coll Health. 2016 Aug-Sep;64(6):490-5. doi: 10.1080/07448481.2016.1138481. Epub 2016 Jan 30.

16.

Impact of the US Two-dose Varicella Vaccination Program on the Epidemiology of Varicella Outbreaks: Data from Nine States, 2005-2012.

Leung J, Lopez AS, Blostein J, Thayer N, Zipprich J, Clayton A, Buttery V, Andersen J, Thomas CA, Del Rosario M, Seetoo K, Woodall T, Wiseman R, Bialek SR.

Pediatr Infect Dis J. 2015 Oct;34(10):1105-9. doi: 10.1097/INF.0000000000000821.

17.

Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009-2010.

Lebo EJ, Kruszon-Moran DM, Marin M, Bellini WJ, Schmid S, Bialek SR, Wallace GS, McLean HQ.

Open Forum Infect Dis. 2015 Feb 20;2(1):ofv006. doi: 10.1093/ofid/ofv006. eCollection 2015 Jan.

18.

Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.

Marin M, Yawn BP, Hales CM, Wollan PC, Bialek SR, Zhang J, Kurland MJ, Harpaz R.

Hum Vaccin Immunother. 2015;11(5):1157-64. doi: 10.1080/21645515.2015.1016681.

19.

Trends in varicella mortality in the United States: Data from vital statistics and the national surveillance system.

Leung J, Bialek SR, Marin M.

Hum Vaccin Immunother. 2015;11(3):662-8. doi: 10.1080/21645515.2015.1008880.

20.

An evaluation of voluntary 2-dose varicella vaccination coverage in New York City public schools.

Doll MK, Rosen JB, Bialek SR, Szeto H, Zimmerman CM.

Am J Public Health. 2015 May;105(5):972-9. doi: 10.2105/AJPH.2014.302229. Epub 2014 Dec 18.

Supplemental Content

Loading ...
Support Center